Back to MGX
MORGAN STANLEY MGX Position History
Metagenomi Therapeutics, Inc.
Quarters held
45
Latest value
$1K
Q2 2026
Peak value
$2.1M
First seen
Q2 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2024 | $146K |
| Q2 2024 | $23K |
| Q2 2024 | $4K |
| Q2 2024 | $261 |
| Q2 2024 | $9K |
| Q3 2024 | $501 |
| Q3 2024 | $91 |
| Q3 2024 | $35K |
| Q3 2024 | $2K |
| Q3 2024 | $5K |
| Q3 2024 | $98K |
| Q4 2024 | $7K |
| Q4 2024 | $2.1M |
| Q4 2024 | $58K |
| Q4 2024 | $96K |
| Q4 2024 | $506K |
| Q1 2025 | $6K |
| Q1 2025 | $201 |
| Q1 2025 | $50K |
| Q1 2025 | $35K |
| Q1 2025 | $32K |
| Q1 2025 | $140K |
| Q2 2025 | $191K |
| Q2 2025 | $93K |
| Q2 2025 | $43K |
| Q2 2025 | $955 |
| Q2 2025 | $41K |
| Q3 2025 | $335K |
| Q3 2025 | $186K |
| Q3 2025 | $10K |
| Q3 2025 | $41K |
| Q3 2025 | $335K |
| Q3 2025 | $186K |
| Q3 2025 | $10K |
| Q3 2025 | $41K |
| Q4 2025 | $87K |
| Q4 2025 | $7K |
| Q4 2025 | $3K |
| Q4 2025 | $87K |
| Q4 2025 | $7K |
| Q4 2025 | $3K |
| Q1 2026 | $6K |
| Q1 2026 | $31K |
| Q2 2026 | $5K |
| Q2 2026 | $1K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $1K | 1.1K | — | — |
| Q2 2026 | $5K | 4.2K | — | — |
| Q1 2026 | $31K | 23.3K | — | — |
| Q1 2026 | $6K | 4.2K | — | — |
| Q4 2025 | $3K | 1.9K | — | — |
| Q4 2025 | $7K | 4.2K | — | — |
| Q4 2025 | $87K | 53.6K | — | — |
| Q4 2025 | $3K | 1.9K | — | — |
| Q4 2025 | $7K | 4.2K | — | — |
| Q4 2025 | $87K | 53.6K | — | — |
| Q3 2025 | $41K | 17.2K | — | — |
| Q3 2025 | $10K | 4.2K | — | — |
| Q3 2025 | $186K | 78.5K | — | — |
| Q3 2025 | $335K | 141.4K | — | — |
| Q3 2025 | $41K | 17.2K | — | — |
| Q3 2025 | $10K | 4.2K | — | — |
| Q3 2025 | $186K | 78.5K | — | — |
| Q3 2025 | $335K | 141.4K | — | — |
| Q2 2025 | $41K | 27.8K | — | — |
| Q2 2025 | $955 | 645 | — | — |
| Q2 2025 | $43K | 29.2K | — | — |
| Q2 2025 | $93K | 63.1K | — | — |
| Q2 2025 | $191K | 129.4K | — | — |
| Q1 2025 | $140K | 102.7K | — | — |
| Q1 2025 | $32K | 23.8K | — | — |
| Q1 2025 | $35K | 26.0K | — | — |
| Q1 2025 | $50K | 36.9K | — | — |
| Q1 2025 | $201 | 148 | — | — |
| Q1 2025 | $6K | 4.2K | — | — |
| Q4 2024 | $506K | 140.2K | — | — |
| Q4 2024 | $96K | 26.5K | — | — |
| Q4 2024 | $58K | 16.0K | — | — |
| Q4 2024 | $2.1M | 591.2K | — | — |
| Q4 2024 | $7K | 1.8K | — | — |
| Q3 2024 | $98K | 45.0K | — | — |
| Q3 2024 | $5K | 2.2K | — | — |
| Q3 2024 | $2K | 1.0K | — | — |
| Q3 2024 | $35K | 16.1K | — | — |
| Q3 2024 | $91 | 42 | — | — |
| Q3 2024 | $501 | 231 | — | — |
| Q2 2024 | $9K | 2.3K | — | — |
| Q2 2024 | $261 | 64 | — | — |
| Q2 2024 | $4K | 1.0K | — | — |
| Q2 2024 | $23K | 5.6K | — | — |
| Q2 2024 | $146K | 35.7K | — | — |